Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma

OBJECTIVE: In this study, we investigated the feasibility of a double-suici de gene/prodrug therapy, involving direct introduction of the herpes simple x virus Type 1 thymidine kinase (TK) gene and the Escherichia coli cytosine deaminase (CD) gene, via a recombinant adenoviral vector, and ganciclovir (GCV) and/or 5-fluorocytosine (5-FC) treatment, in a rat C6 glioma model. METHODS: Efficient gene transfer and transduction of C6 glioma cells via a recombinant adenovirus were evaluated by infecting cells with adenovirus be aring the beta-galactosidase gene and then staining cells with X-5-bromo-4- chloro-3-indolyl-13-D-galactoside. CD/TK expression in cells infected with adenovirus bearing the CD/TK gene (ad-CD/TK) was examined by immunoblotting analysis. For in vitro cytotoxicity experiments, the cells were infected w ith ad-CD/TK or ad-Delta E1 (as a control). After the addition of a variety of concentrations of GCV and 5-FC, either separately or in combination, ce ll viability was determined by staining the cells with crystal violet solut ion 6 days after infection. For in vivo antitumor experiments, 1 x 10(5) ce lls were stereotactically injected into the right caudate-putamen of female Wistar rat brains. At 3 days after implantation, 1 x 10(8) plaque-forming units of ad-CD/TK or ad-Delta E1 (as a control) were stereotactically injec ted into the tumors and GCV (25 mg/kg) and 5-FC (250 mg/kg), alone or in co mbination, were intraperitoneally administered. Animals were then killed, a nd tumor volumes were measured by determining the tumor area in every fifth section, using a light microscope. RESULTS: C6 glioma cells were efficiently transduced with recombinant adeno viral vector at multiplicities of infection of 200 or more. In vitro cytoto xicity of GCV and/or 5-FC, either alone or in combination, was exclusively observed in the cells transduced with ad-CD/TK. Obvious cytotoxicity (>50% inhibition) was observed in the presence of 5-FC at concentrations greater than 30 mu g/ml or GCV at concentrations greater than 0.3 mu g/ml at a mult iplicity of infection of 100. Additionally, cytotoxicity in the presence of both GCV and 5-FC was greater than that after single-prodrug treatments, i ndicating additive effects of the prodrug treatments. In in vivo experiment s, the tumor volumes of the rats treated with GCV or 5-FC alone after ad-CD /TK injection (59.1 +/- 4.6 and 57.4 +/- 7.1 mm(3), respectively) were sign ificantly smaller than that of the control rats (157 +/- 8.9 mm3, P < 0.05) . Furthermore, the tumor volume of the rats treated with GCV and 5-FC in co mbination was 14.7 +/- 1.8 mm(3). CONCLUSION: These results demonstrated the efficient transduction of C6 gli oma cells with a recombinant adenovirus and the additive effects of CD/TK f usion gene/GCV/5-FC treatment, compared with single-gene therapy with the T K or CD gene. Therefore, our data suggest that the direct administration of a double-suicide gene/prodrug therapy has great potential in the treatment of brain tumors.